Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Beta Amino Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113755462B reveals high-activity enzyme mutants for chiral beta-amino acid synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel silver-catalyzed route for beta-amino phosphonic acids. High yield, mild conditions, scalable for pharma intermediates.
Patent CN110950906B reveals a mild silver-catalyzed route for beta-amino phosphoric acid derivatives, offering cost reduction and scalable pharmaceutical intermediate manufacturing.
Patent CN107382783A reveals a solvent-free organocatalytic route for chiral beta-amino acids. Discover cost reduction in fine chemical manufacturing and reliable supply chain solutions.
Patent CN101248037A reveals organocatalytic kinetic resolution for beta-amino acids, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN1260364C reveals a novel enzymatic hydrolysis using bulky esters for high-purity beta-amino acids, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN107384980A reveals efficient Reformatsky and lipase resolution for beta-hydroxy-gamma-amino acids, offering cost reduction and supply reliability for pharma intermediates.
Patent CN112778162B details a mild Wolff rearrangement route for chiral beta-(Boc-amino)-5-hexynoic acid, offering high purity and scalable API intermediate manufacturing.
Patent CN118063351B reveals immobilized enzyme process for high-purity chiral beta-amino acids, offering cost reduction and supply chain reliability for pharmaceutical manufacturing.
Advanced Ir-catalyzed asymmetric hydrogenation for beta-amino acid esters. Delivers 99% ee and 95% yield. Reliable pharmaceutical intermediates supplier for scalable production.
Patent CN113354554B details an efficient Iridium-catalyzed asymmetric hydrogenation route for carbapenem intermediates, offering superior stereoselectivity and scalable manufacturing capabilities.
Patent CN1972898A details a novel Rh-catalyzed asymmetric hydrogenation process for unprotected beta-amino acids, offering significant cost reduction and streamlined API manufacturing.
Patent CN101525299B reveals a novel one-pot synthesis for beta-amino acids using benzylamine protection, offering significant cost reduction and simplified purification for pharmaceutical intermediates.
Patent CN110869383A reveals enzymatic synthesis of beta-hydroxy-alpha-amino acids with high stereoselectivity and reduced environmental impact for supply chains.
Patent CN107304176A details a mild chiral synthesis route for alpha-fluoro beta-amino acids, offering high optical purity and scalable manufacturing for pharmaceutical intermediates.
Patent CN102432485B details a novel Rh-catalyzed four-component reaction for high-purity alpha,beta-diamino acid derivatives, offering significant cost reduction in API manufacturing.
Patent CN1435408A reveals a cost-effective one-step hydrogenation route for beta-amino acids. Discover scalable manufacturing advantages for pharmaceutical intermediates.
Patent CN1761642A details an efficient asymmetric hydrogenation process for chiral beta-amino acids, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN1168883A reveals a novel 3-stage synthesis for high-purity cyclopentane-beta-amino acids, offering superior enantioselectivity and streamlined manufacturing for global supply chains.
Patent CN103998618A reveals enzymatic hydrolysis for high-purity chiral intermediates. Discover supply chain advantages and cost reduction strategies.